Is diffusion magnetic resonance imaging the future biomarker to measure therapeutic efficacy in multiple sclerosis?

Click here to view the accompanying paper in this volume.

Saved in:
Bibliographic Details
Published inEuropean journal of neurology Vol. 25; no. 5; pp. 707 - 708
Main Authors Kincses, Z. T., Vécsei, L.
Format Journal Article
LanguageEnglish
Published England John Wiley & Sons, Inc 01.05.2018
Subjects
Biomarkers
Diffusion Magnetic Resonance Imaging
Dimethyl Fumarate
Humans
Longitudinal Studies
Magnetic resonance imaging
Multiple Sclerosis
White Matter
Online AccessGet full text

Cover

More Information
Summary:Click here to view the accompanying paper in this volume.
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Editorial-2
ObjectType-Commentary-1
ISSN:1351-5101
1468-1331
DOI:10.1111/ene.13591